Yahoo Web Search

Search results

1. • 

     Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief

     Verywell Health via Yahoo News· 3 days ago

     Takeaway Humira was one of the first biologic medications approved for psoriatic arthritis in 2005...

2. • 

     Elizabeth Mellins

     Denver Post· 5 days ago

     Her team investigated how immune cells called monocytes function in diseases including rheumatoid arthritis, Still disease, psoriatic arthritis, asthma,...

3. • 

     Guselkumab Continues Winning Streak in Crohn's Disease

     MedPage Today· 2 days ago

     Induction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...

4. • 

     Maintenance Tx With Guselkumab for UC Meets All Endpoints

     Medscape· 2 days ago

     Guselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...

5. • Alvotech (ALVO) Scheduled to Post Quarterly Earnings on Tuesday

     ETF DAILY NEWS· 5 days ago

     Alvotech (NYSE:ALVO – Get Free Report) will post its quarterly earnings results after the market closes on Tuesday, May 21st. Individual interested in participating in the company’s earnings ...

6. • 

     7 Biotech Stocks That Could Breathe New Life Into Your Portfolio

     InvestorPlace· 4 days ago

     Fundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...

7. • Pizza for Weight Loss? Top MD Says This Dough Makes It Possible

     The Sacramento Bee· 7 days ago

     Called “Fathead” or magic pizza, “the dough is the secret,” says Tennessee family doctor and YouTube keto expert Ken Berry, MD. “In my opinion, it’s better than traditional pizza,” says 60-pounds-slimmer ...

8. • 

     Research shows linked biological pathways driving skin inflammation

     Medical Xpress· 3 days ago

     Inflammation is the body's natural response to irritation and infection, but when out of control, it...

9. • AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...

     Tri-County Times· 7 days ago

     - AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)

10. • Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.

      ETF DAILY NEWS· 4 days ago

      Panagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure ...